Please Wait
Applying Filters...
Menu
Xls
2D Structure
Also known as: L3l3xyp7mp, Lmwd, Schembl206877, Chembl1697742, O-alpha-d-glucopyranosyl-(1.6)-o-alpha-d-glucopyranosyl-(1.6)-d-glucose, Hy-n0913a
Molecular Formula
C18H32O16
Molecular Weight
504.4  g/mol
InChI Key
FZWBNHMXJMCXLU-BLAUPYHCSA-N
FDA UNII
L3L3XYP7MP

A group of glucose polymers made by certain bacteria. Dextrans are used therapeutically as plasma volume expanders and anticoagulants. They are also commonly used in biological experimentation and in industry for a wide variety of purposes.
1 2D Structure

2D Structure

2 Identification
2.1 Computed Descriptors
2.1.1 IUPAC Name
(2R,3S,4R,5R)-2,3,4,5-tetrahydroxy-6-[(2S,3R,4S,5S,6R)-3,4,5-trihydroxy-6-[[(2S,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxymethyl]oxan-2-yl]oxyhexanal
2.1.2 InChI
InChI=1S/C18H32O16/c19-1-5(21)9(23)10(24)6(22)3-31-17-16(30)14(28)12(26)8(34-17)4-32-18-15(29)13(27)11(25)7(2-20)33-18/h1,5-18,20-30H,2-4H2/t5-,6+,7+,8+,9+,10+,11+,12+,13-,14-,15+,16+,17-,18-/m0/s1
2.1.3 InChI Key
FZWBNHMXJMCXLU-BLAUPYHCSA-N
2.1.4 Canonical SMILES
C(C1C(C(C(C(O1)OCC2C(C(C(C(O2)OCC(C(C(C(C=O)O)O)O)O)O)O)O)O)O)O)O
2.1.5 Isomeric SMILES
C([C@@H]1[C@H]([C@@H]([C@H]([C@H](O1)OC[C@@H]2[C@H]([C@@H]([C@H]([C@H](O2)OC[C@H]([C@H]([C@@H]([C@H](C=O)O)O)O)O)O)O)O)O)O)O)O
2.2 Other Identifiers
2.2.1 UNII
L3L3XYP7MP
2.3 Synonyms
2.3.1 MeSH Synonyms

1. Dextran

2. Dextran 40000

3. Dextran 70

4. Dextran 75

5. Dextran 80

6. Dextran B 1355

7. Dextran B 1355 S

8. Dextran B-1355

9. Dextran B-1355-s

10. Dextran B1355

11. Dextran B512

12. Dextran Derivatives

13. Dextran M 70

14. Dextran T 40

15. Dextran T 500

16. Dextran T 70

17. Dextran T-40

18. Dextran T-500

19. Dextrans

20. Hemodex

21. Hyskon

22. Infukoll

23. Macrodex

24. Polyglucin

25. Promit

26. Rheodextran

27. Rheoisodex

28. Rheomacrodex

29. Rheopolyglucin

30. Rondex

31. Saviosol

2.3.2 Depositor-Supplied Synonyms

1. L3l3xyp7mp

2. Lmwd

3. Schembl206877

4. Chembl1697742

5. O-alpha-d-glucopyranosyl-(1.6)-o-alpha-d-glucopyranosyl-(1.6)-d-glucose

6. Hy-n0913a

7. Dtxsid701317190

8. 6-.alpha.-isomaltosylglucose

9. Zinc64622163

10. Cs-0109495

11. D-glucose, O-.alpha.-d-glucopyranosyl-(1->6)-o-.alpha.-d-glucopyranosyl-(1->6)-

12. O-alpha-d-glucopyranosyl-(1-->6)-o-alpha-d-glucopyranosyl-(1-->6)-d-glucose

13. Wurcs=2.0/2,3,2/[o2122h][a2122h-1a_1-5]/1-2-2/a6-b1_b6-c1

14. (2r,3s,4r,5r)-2,3,4,5-tetrahydroxy-6-(((2s,3r,4s,5s,6r)-3,4,5-trihydroxy-6-((((2s,3r,4s,5s,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl)oxy)methyl)oxan-2-yl)oxy)hexanal

2.4 Create Date
2004-09-16
3 Chemical and Physical Properties
Molecular Weight 504.4 g/mol
Molecular Formula C18H32O16
XLogP3-7.2
Hydrogen Bond Donor Count11
Hydrogen Bond Acceptor Count16
Rotatable Bond Count11
Exact Mass504.16903493 g/mol
Monoisotopic Mass504.16903493 g/mol
Topological Polar Surface Area277 Ų
Heavy Atom Count34
Formal Charge0
Complexity625
Isotope Atom Count0
Defined Atom Stereocenter Count14
Undefined Atom Stereocenter Count0
Defined Bond Stereocenter Count0
Undefined Bond Stereocenter Count0
Covalently Bonded Unit Count1
4 Pharmacology and Biochemistry
4.1 MeSH Pharmacological Classification

Anticoagulants

Agents that prevent BLOOD CLOTTING. (See all compounds classified as Anticoagulants.)


Plasma Substitutes

Any liquid used to replace blood plasma, usually a saline solution, often with serum albumins, dextrans or other preparations. These substances do not enhance the oxygen- carrying capacity of blood, but merely replace the volume. They are also used to treat dehydration. (See all compounds classified as Plasma Substitutes.)


4.2 FDA Pharmacological Classification
4.2.1 Pharmacological Classes
Osmotic Activity [MoA]; Plasma Volume Expander [EPC]; Increased Intravascular Volume [PE]